|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 1/113 | |
| C07K 16/18 | |||
| A61K 39/395 | |||
| C07K 16/28 |
| (11) | Patento numeris | 3286204 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16719824.1 |
| Europos patento paraiškos padavimo data | 2016-04-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-02-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/059051 |
| Data | 2016-04-22 |
| (87) | Numeris | WO 2016/170138 |
| Data | 2016-10-27 |
| (30) | Numeris | Data | Šalis |
| 201506870 | 2015-04-22 | GB |
| (72) |
HEYWOOD, Sam Philip, GB
WILD, Gavin Barry, GB
HANIF, Razwan, GB
LE PAGE, Christopher John, GB
|
| (73) |
UCB Biopharma SRL,
Allée de la Recherche 60, 1070 Brussels,
BE
|
| (54) | METHOD OF MONOMERISATION OF RECOMBINANT ANTIBODY MOLECULES |
| METHOD OF MONOMERISATION OF RECOMBINANT ANTIBODY MOLECULES |